Cannabis Market in Texas

Only CBD products are legal in Texas; recreational and medical cannabis remain prohibited.

Texas has one of the most restrictive medical cannabis programs in the country. The Texas Compassionate Use Act, signed in 2015, created the Compassionate Use Program (CUP), initially limited to patients with intractable epilepsy and restricted to low-THC cannabis products. HB 1535, passed in 2021, expanded the program to include additional qualifying conditions such as cancer, PTSD, and certain neurodegenerative diseases, and raised the THC cap from 0.5% to 1%. Despite these expansions, the program remains far more limited than standard medical cannabis programs in other states.

The Texas market structure is extraordinarily restrictive. Only 3 vertically integrated dispensing organizations are licensed to operate statewide, serving a population of approximately 30 million people. This creates significant access challenges for patients, as the limited number of dispensary locations cannot adequately serve the state's vast geography. Products are limited to low-THC cannabis preparations, and the 1% THC cap means patients cannot access the full-potency products available in most medical states.

Despite being the second most populous state, Texas generates modest cannabis revenue estimated at roughly $50 million annually from its CUP program. The extremely limited license structure, low THC cap, and restricted qualifying conditions severely constrain the market. No major MSOs currently operate in Texas, as the 3 existing licenses are held by local operators. If Texas were to significantly expand its medical program or legalize recreational cannabis, it would instantly become one of the largest cannabis markets in the world. Market analysts estimate a fully legalized Texas market could generate $3-5 billion in annual sales, making it a closely watched state for potential reform.

The Texas cannabis market is regulated by the Texas Department of Public Safety — Compassionate Use Program, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in Texas is: No specific cannabis excise tax; standard 6.25% state sales tax applies. Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in Texas must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the Texas cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $50M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with Texas operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.